Expert equity analysis, earnings previews, and data-driven market research.
Growth at a cost. PDD Holdings delivered Q4 2025 revenue of ¥123.91 billion, marking 12.0% year-over-year growth, but the top-line expansion came with a pro...
Date: 25/03/2026 Introduction Salesforce Inc. (NYSE: CRM) is poised to navigate fiscal year 2027 with a strategic focus on three...
Intrusion Inc. missed Q4 earnings expectations by a substantial margin, though the miss obscures a more complex story of contract...
KB Home stumbled in its fiscal first quarter, missing consensus estimates as a deteriorating housing market environment compressed...
LightInTheBox delivered a powerful profitability inflection in Q4 2025, with adjusted EPS surging 800.0% year-over-year to $0.18 as...
Broadcom Inc. (NASDAQ: AVGO) is positioning for sustained growth as hyperscale customers increase spending on AI infrastructure and...
Company Overview M-tron Industries, Inc. is a U.S.-based designer and manufacturer of highly-engineered electronic components for the aerospace,...
Company Overview Reed’s, Inc. is a leading provider of natural, handcrafted craft beverages, operating under the Reed’s, Virgil’s,...
Company Overview Compass Pathways plc is a biotechnology company developing COMP360, an investigational synthetic psilocybin therapy for mental...
Company Overview LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ (aceclidine ophthalmic solution) 1.44%...
Company Overview Neurogene is a clinical-stage biotechnology company focused on developing genetic medicines for individuals and families affected...
Company Overview Velo3D, Inc. is an additive manufacturing technology company that transforms aerospace and defense supply chains with...
Company Overview Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer...
NVIDIA (NVDA) is positioning for a potential re-acceleration of data center growth by adapting its AI accelerator lineup...
Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases....
